1/ The key bottleneck to scaling mRNA vaccines is a "worldwide shortage of essential components... nucleotides, enzymes, & lipids", according to this piece.
But...companies that can do this are not licensing their manufacturing so that others can join in nature.com/articles/d4158…
But...companies that can do this are not licensing their manufacturing so that others can join in nature.com/articles/d4158…
2/ So, once again, the issues we are facing are *man-made*
They are issues with how financial incentives overpower global health equity
There are ways that we could scale up more right now; but that won't happen because it threatens wealth
@gregggonsalves @PeterHotez
They are issues with how financial incentives overpower global health equity
There are ways that we could scale up more right now; but that won't happen because it threatens wealth
@gregggonsalves @PeterHotez
3/ These are complicated matters. But the system as it stands is not designed for health emergencies: it generates products (i.e. vaccines) for the few who can afford them; everyone else is subject to 'charity'
Even during a pandemic.
#covid19
Even during a pandemic.
#covid19
cc @JoiaMukherjee @RanuDhillon @DrMishalK @richardhorton1 @DrWilfredoM @drlouiseivers @drdavidwalton @DrDavidDuong @IngridKatzMD @ashishkjha @rajpanjabi @seyeabimbola @paimadhu
• • •
Missing some Tweet in this thread? You can try to
force a refresh
